Loading...
Xvivo Perfusion AB (publ)
XVIPY•PNK
Healthcare
Medical - Specialties
$5.70
$5.70(4.552715654952077e+29%)
Xvivo Perfusion AB (publ) (XVIPY) Financial Performance & Statements
Review Xvivo Perfusion AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
37.63%
↑ 37.63%
Operating Income Growth
2010.17%
↑ 2010.17%
Net Income Growth
87.52%
↑ 87.52%
Operating Cash Flow Growth
140.43%
↑ 140.43%
Operating Margin
6.36%
↑ 6.36%
Gross Margin
70.51%
↑ 70.51%
Net Profit Margin
27.21%
↑ 27.21%
ROE
10.14%
↑ 10.14%
ROIC
2.24%
↑ 2.24%
Xvivo Perfusion AB (publ) (XVIPY) Financial Statements
Explore quarterly and annual reports for Xvivo Perfusion AB (publ) stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $218.59M | $227.56M | $198.48M | $210.35M |
| Cost of Revenue | $58.21M | $52.43M | $50.55M | $52.10M |
| Gross Profit | $160.37M | $175.13M | $147.93M | $158.24M |
| Gross Profit Ratio | $0.73 | $0.77 | $0.75 | $0.75 |
| R&D Expenses | $35.48M | $55.81M | $30.86M | $31.07M |
| SG&A Expenses | $96.73M | $103.85M | $95.93M | $94.003M |
| Operating Expenses | $133.81M | $159.67M | $127.46M | $124.82M |
| Total Costs & Expenses | $192.02M | $212.10M | $178.008M | $176.92M |
| Interest Income | $0.00 | $0.00 | $67.21M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $781000.00 |
| Depreciation & Amortization | $16.40M | $0.00 | $0.00 | $10.22M |
| EBITDA | $42.97M | $15.46M | $20.47M | $51.14M |
| EBITDA Ratio | $0.20 | $0.07 | $0.10 | $0.24 |
| Operating Income | $26.57M | $15.46M | $20.47M | $33.43M |
| Operating Income Ratio | $0.12 | $0.07 | $0.10 | $0.16 |
| Other Income/Expenses (Net) | -$40.62M | $34.15M | $67.21M | -$781000.00 |
| Income Before Tax | -$14.05M | $49.62M | $87.68M | $32.65M |
| Income Before Tax Ratio | -$0.06 | $0.22 | $0.44 | $0.16 |
| Income Tax Expense | -$1.65M | $13.23M | $1.86M | $5.45M |
| Net Income | -$12.40M | $36.39M | $85.82M | $27.19M |
| Net Income Ratio | -$0.06 | $0.16 | $0.43 | $0.13 |
| EPS | -$0.39 | $1.16 | $2.72 | $0.86 |
| Diluted EPS | -$0.39 | $1.15 | $2.71 | $0.86 |
| Weighted Avg Shares Outstanding | $31.50M | $31.50M | $31.50M | $31.62M |
| Weighted Avg Shares Outstanding (Diluted) | $31.65M | $31.65M | $31.69M | $31.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan